Expression of CD40 correlates negatively with overall and progression-free 
survival of low- and high-grade gliomas

Werner, Jan-Michael; Kuhl, Saskia; Ulrich, Katharina; Krischek, Boris; Stavrinou, Pantelis; Goldbrunner, Roland; Timer, Marco

doi:10.1016/j.wneu.2019.05.112

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Expression of CD40 correlates negatively with overall and progression-free survival of low- and high-grade gliomas

MPS-Authors

/persons/resource/persons239909

Timer, Marco
In-vivo-NMR, Research Groups, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Werner, J.-M., Kuhl, S., Ulrich, K., Krischek, B., Stavrinou, P., Goldbrunner, R., et al. (2019). Expression of CD40 correlates negatively with overall and progression-free survival of low- and high-grade gliomas. World Neurosurgery, 130, E17-E25. doi:10.1016/j.wneu.2019.05.112.

Cite as: https://hdl.handle.net/21.11116/0000-0004-5018-7

Abstract

There is no abstract available